With particular relevance to GBM, the cytokines GCSF and GM-CSF were highly upregulated in response to ID12-RT treatment, both of which have been implicated in establishing and promoting the hostile immunosuppressive tumour microenvironment of GBM and tumour progression [36,37]. This evidence concerns the gene CSF3 and glioblastoma.